HIC1 hypermethylation is a late event in hematopoietic neoplasms

Cancer Research

Volumn 57, Issue 9, 1997, Pages 1678-1681

  Issa, Jean Pierre J ^a,b   Zehnbauer, Barbara A ^a,c   Kaufmann, Scott H ^a,d   Biel, Maggie A ^a   Baylin, Stephen B ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c WASHINGTON UNIVERSITY   (United States)

^d MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LYMPHOCYTIC LEUKEMIA; ARTICLE; CANCER GENETICS; CANCER RECURRENCE; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; DNA DETERMINATION; DNA METHYLATION; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL;

BONE MARROW; CELLS, CULTURED; DEOXYRIBONUCLEASES, TYPE II SITE-SPECIFIC; DNA METHYLATION; DNA, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; LEUKEMIA; LYMPHOMA, NON-HODGKIN; NEOPLASM RECURRENCE, LOCAL; RESTRICTION MAPPING; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 0030969482     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Wales, M. M., Biel, M. A., el Deiry, W., Nelkin, B. D., Issa, J. P., Cavenee, W. K., Kuerbitz, S. J., and Baylin, S. B. p53 activates expression of HIC-1, a new candidate tumor suppressor gene on 17p13.3. Nat. Med., 1: 570-577, 1995.
2. Makos, M., Nelkin, B. D., Lerman, M. I., Latif, F., Zbar, B., and Baylin, S. B. Distinct hypermethylation patterns occur at altered chromosome loci in human lung and colon cancer. Proc. Natl. Acad. Sci. USA, 89: 1929-1933, 1992.
3. Makos, M., Nelkin, B. D., Chazin, V. R., Cavenee, W. K., Brodeur, G. M., and Baylin, S. B. DNA hypermethylation is associated with 17p allelic loss in neural tumors. Cancer Res., 53: 2715-2718, 1993.
4. Makos, M., Nelkin, B. D., Reiter, R. E., Gnarra, J. R., Brooks, J., Isaacs, W., Linehan, M., and Baylin, S. B. Regional DNA hypermethylation at D17S5 precedes 17p structural changes in the progression of renal tumors. Cancer Res., 53: 2719-2722, 1993.
5. Cornelis, R. S., van Vliet, M., Vos, C. B., Cleton-Jansen, A. M., van de Vijver, M. J., Peterse, J. L., Khan, P. M., Borresen, A. L., Cornelisse, C. J., and Devilee, P. Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations. Cancer Res., 54: 4200-4206, 1994.
6. Phillips, N. J., Ziegler, M. R., Radford, D. M., Fair, K. L., Steinbrueck, T., Xynos, F. P., and Donis-Keller, H. Allelic deletion on chromosome 17p13.3 in early ovarian cancer. Cancer Res., 56: 606-611, 1996.
7. Schultz, D. C., Vanderveer, L., Berman, D. B., Hamilton, T. C., Wong, A. J., and Godwin, A. K. Identification of two candidate tumor suppressor genes on chromosome 17p13.3. Cancer Res., 56: 1997-2002, 1996.
8. Schoch, C., Rieder, H., Stollmann-Gibbels, B., Freund, M., Tischler, H. J., Silling-Engelhardt, G., and Fonatsch, C. 17p anomalies in lymphoid malignancies: diagnostic and prognostic implications. Leuk. Lymphoma, 17: 271-279, 1995.
9. Nakai, H., and Misawa, S. Chromosome 17 abnormalities and inactivation of the p53 gene in chronic myeloid leukemia and their prognostic significance. Leuk. Lymphoma, 19: 213-221, 1995.
10. Imamura, J., Miyoshi, I., and Koeffler, H. P. p53 in hematologic malignancies. Blood, 84: 2412-2421, 1994.
11. Newcomb, E. W. p53 gene mutations in lymphoid diseases and their possible relevance to drug resistance. Leuk. Lymphoma. 17: 211-221, 1995.
12. Miki, T., Kawamata, N., Hirosawa, S., and Aoki, N. Gene involved in the 3q27 translocation associated with B-cell lymphoma, bc15, encodes a Kruppel-like zinc finger protein. Blood, 83: 26-32, 1994.
13. Chen, Z., Brand, N. J., Chen, A., Chen, S. J., Tong, J. H., Wang, Z. Y., Waxman, S., and Zelent, A. Fusion between a novel Kruppel-like zinc finger gene and the retinoic acid receptor a locus due to a variant t(11;17) translocation associated with acute promyelocytic leukaemia. EMBO J., 12: 1161-1167, 1993.
14. Issa, J. P. J., Baylin, S. B., and Herman, J. G. DNA methylation changes in hematologic malignancies: biologic and clinical implications. Leukemia (Baltimore), in press, 1997.
15. Issa, J. P. J., Zehnbauer, B. A., Civin, C. I., Collector, M. I., Sharkis, S. J., Davidson, N. E., Kaufmann. S. H., and Baylin, S. B. The estrogen receptor CpG island is methylated in most hematopoietic neoplasms. Cancer Res., 56: 973-977, 1996.
16. Herman, J. G., Civin, C. I., Issa, J. P. J., Collector, M. I., Sharkis, S. J., and Baylin, S. B. Distinct patterns of p15INK4B and p16INK4A characterize the major types of hematologic malignancies. Cancer Res., 57: 837-841, 1997.
17. Zion, M., Ben-Yehuda, D., Avraham, A., Cohen, O., Wetzler, M., Melloul, D., and Ben-Neriah, Y. Progressive de novo DNA methylation at the bcr-abl locus in the course of chronic myelogenous leukemia. Proc. Natl. Acad. Sci. USA, 91: 10722-10726, 1994.
18. Morton, R. A., Jr., Watkins, J. J., Bova, G. S., Wales, M. M., Baylin, S. B., and Isaacs, W. B. Hypermethylation of chromosome 17P locus D17S5 in human prostate tissue. J. Urol., 156: 512-516, 1996.
19. Pieretti, M., Powell, D. E., Gallion, H. H., Conway, P. S., Case, E. A., and Turker, M. S. Hypermethylation at a chromosome 17 "hot spot" is a common event in ovarian cancer. Hum. Pathol., 26: 398-401, 1995.
20. Nyce, J., Leonard, S., Canupp, D., Schulz, S., and Wong, S. Epigenetic mechanisms of drug resistance: drug-induced DNA hypermethylation and drug resistance. Proc. Natl. Acad. Sci. USA, 90: 2960-2964, 1993.
21. Baylin, S. B., Fearon, E. R., Vogelstein, B., de Bustros, A., Sharkis, S. J., Burke, P. J., Staal, S. P., and Nelkin, B. D. Hypermethylation of the 5′ region of the calcitonin gene is a property of human lymphoid and acute myeloid malignancies. Blood, 70: 412-417, 1987.
22. Hunt, P. A., and Burgoyne, P. S. A tissue-specific fragile site associated with the sex reversed (Sxr) mutation in the mouse. Chromosoma (Berl.), 96: 67-71, 1987.
23. Liu, Q., Shalaby, F., Puri, M. C., Tang, S., and Breitman, M. L. Novel zinc finger proteins that interact with the mouse γ F-crystallin promoter and are expressed in the sclerotome during early somitogenesis. Dev. Biol., 165: 165-177, 1994.
24. Herman, J. G., Graff, J. R., Myöhänen, S., Nelkin, B. D., and Baylin, S. B. Methylalion-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc. Natl. Acad. Sci. USA, 93: 9821-9826, 1996.
25. Kantarjian, H. M., Estey, E. H., and Keating, M. A. New chemotherapeutic agents in acute myeloid leukemia. Leukemia (Baltimore), 10 (Suppl. 1): S4-S6, 1996.